MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Dietary Intervention Study in Children (DISC)

Phase 3
Completed
Conditions
Heart Diseases
Hypercholesterolemia
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-05-05
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000459

Systolic Hypertension in the Elderly Program (SHEP)

Phase 3
Completed
Conditions
Heart Diseases
Hypertension
Cardiovascular Diseases
Cerebrovascular Disorders
First Posted Date
1999-10-28
Last Posted Date
2016-04-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000514

Women's Health Initiative (WHI)

Phase 3
Completed
Conditions
Breast Neoplasms
Cardiovascular Diseases
Coronary Disease
Colonic Neoplasms
Heart Diseases
Myocardial Ischemia
Postmenopause
Bone Diseases
Osteoporosis
First Posted Date
1999-10-28
Last Posted Date
2016-04-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000611

Aspirin-Myocardial Infarction Study (AMIS)

Phase 3
Completed
Conditions
Heart Diseases
Coronary Disease
Cardiovascular Diseases
Myocardial Infarction
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-03-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000491

Emory Angioplasty Versus Surgery Trial (EAST)

Phase 3
Completed
Conditions
Heart Diseases
Coronary Disease
Myocardial Ischemia
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000465

Estrogen and Graft Atherosclerosis Research Trial (EAGER)

Phase 3
Completed
Conditions
Coronary Arteriosclerosis
Myocardial Ischemia
Postmenopause
Heart Diseases
Cardiovascular Diseases
Coronary Disease
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000605

Beta-Blocker Evaluation in Survival Trial (BEST)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Heart Failure, Congestive
Heart Failure
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000560

Digitalis Investigation Group (DIG)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Arrhythmia
Heart Diseases
Heart Failure, Congestive
Sinus Arrhythmia
Heart Failure
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000476

NHLBI Type II Coronary Intervention Study

Phase 3
Completed
Conditions
Cardiovascular Diseases
Hypercholesterolemia, Familial
Myocardial Infarction
Heart Diseases
Myocardial Ischemia
Coronary Disease
First Posted Date
1999-10-28
Last Posted Date
2012-04-27
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000594

Cholesterol Reduction in Seniors Program (CRISP)

Phase 2
Completed
Conditions
Atherosclerosis
Hypercholesterolemia
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000477
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy